Comparing etrasimod vs mesalazine in Chinese adults with active ulcerative colitis
Treatments studied
Part of Digestive system clinical trials.
This trial compares two medicines — etrasimod (a new pill) and mesalazine (a standard anti-inflammatory) — to see which works better and is safer for Chinese adults with active ulcerative colitis. Participants will receive one of the two treatments, and the study aims to find if the newer drug offers more benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have active ulcerative colitis (Mayo score between 3 and 6), with at least some inflammation visible on scope.
- If you have proctitis (inflammation in the rectum only), it must extend more than 5 cm from the anal verge.
- You must not have previously used biologics or small-molecule drugs for UC.
- You must not have a recent severe UC flare requiring hospitalization, a colostomy, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how well etrasimod works for people with active ulcerative colitis. If you are already taking etrasimod and started it within the last 6 months, you may be able to join and help researchers learn more about its benefits.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This trial tests whether exosomes (tiny particles) from human umbilical cord stem cells can help treat active ulcerative colitis. It is for people who have not responded well to standard treatments or cannot tolerate them.
This study watches how well etrasimod works for adults with moderate to severe ulcerative colitis (UC). You must already be prescribed etrasimod by your doctor, and the study collects information through a web-based tool.
This study tests whether adding acupuncture (using small intradermal needles) to the standard medication mesalazine improves outcomes for people with mild-to-moderate ulcerative colitis. Participants receive 12 acupuncture sessions and undergo two colonoscopies to assess the treatment's effect.
This trial tests an oral medication called etrasimod for elderly patients with active ulcerative colitis. It aims to see if the drug is safe and effective in reducing inflammation and symptoms.
Hear when a new Etrasimod trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.